These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 30148169)

  • 21. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors.
    Hashemi M; Daneii P; Asadalizadeh M; Tabari K; Matinahmadi A; Bidoki SS; Motlagh YSM; Jafari AM; Ghorbani A; Dehghanpour A; Nabavi N; Tan SC; Rashidi M; Taheriazam A; Entezari M; Goharrizi MASB
    Int J Biochem Cell Biol; 2024 May; 170():106566. PubMed ID: 38513802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma.
    Falcon T; Freitas M; Mello AC; Coutinho L; Alvares-da-Silva MR; Matte U
    Biomed Res Int; 2018; 2018():2864120. PubMed ID: 30046591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
    J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism.
    Qiu W; Zhang S; Yu W; Liu J; Wu H
    Comput Biol Med; 2024 Sep; 180():108867. PubMed ID: 39089114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment.
    Li C; Yang J; Liu C; Wang X; Zhang L
    Pharmacol Res; 2020 Aug; 158():104848. PubMed ID: 32389858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
    Fang Y; Zhang X; Huang H; Zeng Z
    J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Hao H; Chen L; Shao J
    Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research advances in diagnostic and therapeutic application of long-chain non-coding RNAs in hepatocellular carcinoma].
    Li WX; Li Q; Lin Y; Huang YX; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):628-631. PubMed ID: 27788714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNAs in liver cancer: what we know in 2014.
    Zhao J; Greene CM; Gray SG; Lawless MW
    Expert Opin Ther Targets; 2014 Oct; 18(10):1207-18. PubMed ID: 25145388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding RNAs as biomarkers for hepatocellular carcinoma-A systematic review.
    Zhao J; Wang Y; Su H; Su L
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101736. PubMed ID: 34146723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
    Nie G; Lian N; Peng D; Lu J; Li B
    Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of noncoding RNAs in the tumor microenvironment of hepatocellular carcinoma.
    Yang Q; Tian H; Guo Z; Ma Z; Wang G
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1697-1706. PubMed ID: 37867435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis.
    Yuan D; Chen Y; Li X; Li J; Zhao Y; Shen J; Du F; Kaboli PJ; Li M; Wu X; Ji H; Cho CH; Wen Q; Li W; Xiao Z; Chen B
    Int J Biol Sci; 2021; 17(1):220-235. PubMed ID: 33390845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.